Volume 90, Issue 3, Pages (September 2016)

Slides:

Advertisements

Similar presentations

A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and.

Advertisements

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Volume 54, Pages S135-S139 (December 1998)

A.M. Thompson, T.G. Pickering Kidney International

Nina Vasavada, Rajiv Agarwal Kidney International

Volume 54, Issue 2, Pages (August 1998)

Beta blockers in the management of chronic kidney disease

Plasma sodium and hypertension

Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction

Diagnosis and Management of Chronic Kidney Disease

Anemia management in chronic kidney disease

Volume 83, Issue 3, Pages (March 2013)

Membranous nephropathy: When and how to treat

Prehypertension and chronic kidney disease: the ox or the plow?

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Reassessment of the care of the patient with chronic kidney disease

Volume 88, Issue 6, Pages (December 2015)

Volume 88, Issue 2, Pages (August 2015)

Volume 65, Issue 6, Pages (June 2004)

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 94, Issue 3, Pages (September 2018)

Volume 69, Issue 2, Pages (January 2006)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Gary C.W. Chan, Sydney C.W. Tang Kidney International

The epidemiology of chronic kidney disease

Use of vitamin D in chronic kidney disease patients

Volume 87, Issue 2, Pages (February 2015)

Volume 91, Issue 5, Pages (May 2017)

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

Volume 73, Pages S5-S17 (April 2008)

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments R. Mishler, J.J. Sands, N.J. Ofsthun,

The calcium–phosphorus in guidelines for CKD-MBD

Volume 67, Pages S48-S51 (January 2005)

Blood pressure targets in hemodialysis patients

Volume 72, Issue 12, Pages (December 2007)

Volume 73, Issue 12, Pages (June 2008)

Volume 76, Issue 6, Pages (September 2009)

Volume 67, Issue 1, Pages (January 2005)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Tilman B. Drüeke, Ziad A. Massy Kidney International

Methods for guideline development

Volume 93, Issue 1, Pages (January 2018)

Counteracting progression of renal disease: A look into the future

The global challenge of chronic kidney disease

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 54, Pages S135-S139 (December 1998)

A man with a hole in his penis

Volume 58, Issue 1, Pages (July 2000)

Volume 71, Issue 9, Pages (May 2007)

Carmine Zoccali, Francesca Mallamaci Kidney International

The course of the remnant kidney model in mice

Nina Vasavada, Rajiv Agarwal Kidney International

Volume 72, Issue 2, Pages (July 2007)

Volume 55, Pages S3-S16 (June 1999)

Volume 80, Issue 10, Pages (November 2011)

Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension Julian Segura, Carlos Campo, Luis M. Ruilope Kidney.

Volume 60, Issue 6, Pages (December 2001)

Is it the low-protein diet or simply the salt restriction?

Volume 65, Issue 4, Pages (April 2004)

Importance of blood pressure control in hemodialysis patient survival

Volume 70, Issue 5, Pages (September 2006)

Aldosterone and potassium secretion by the cortical collecting duct

Volume 73, Issue 11, Pages (June 2008)

Antonio Piccoli, Luana Pillon Kidney International

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 90, Issue 3, Pages 696-704 (September 2016) Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors Matthew R. Weir, George L. Bakris, Coleman Gross, Martha R. Mayo, Dahlia Garza, Yuri Stasiv, Jinwei Yuan, Lance Berman, Gordon H. Williams Kidney International Volume 90, Issue 3, Pages 696-704 (September 2016) DOI: 10.1016/j.kint.2016.04.019 Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 1 Observed mean values of serum aldosterone and potassium over time during the initial treatment phase. The observed mean values were measured in a central laboratory. Missing central laboratory serum potassium values were imputed from local laboratory data. Kidney International 2016 90, 696-704DOI: (10.1016/j.kint.2016.04.019) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 2 Effect of patiromer on observed mean values of systolic (a) and diastolic (b) blood pressure over time during the initial treatment phase. Kidney International 2016 90, 696-704DOI: (10.1016/j.kint.2016.04.019) Copyright © 2016 International Society of Nephrology Terms and Conditions